Para and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Para (para - aminobenzoic acid (paba)), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Imuran, and have Ulcerative colitis.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Para. It is created by eHealthMe based on reports of 2,184 people who have side effects when taking Para from the FDA, and is updated regularly.

What is Para?

Para has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 2,194 Para users. Check the latest studies of Para.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,579 drugs and 3,529 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Jan, 27, 2026

2,184 people reported to have side effects when taking Para.
Among them, 18 people (0.82%) have Hyperhidrosis.

Among these 18 people:

How long have people been on Para when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Para? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Hyperhidrosis when taking Para? *

What are other drugs people take besides Para? *

Cortifoam: 5 people, 27.78%
Percocet: 5 people, 27.78%
Imuran: 5 people, 27.78%
Gilenya: 4 people, 22.22%
Lemtrada: 4 people, 22.22%
Alphagan P: 4 people, 22.22%
Gabapentin: 4 people, 22.22%
Solu-Medrol: 4 people, 22.22%
Cosopt: 4 people, 22.22%
Fingolimod Hydrochloride: 3 people, 16.67%

What are other side effects people have besides Hyperhidrosis? *

Headache (pain in head): 11 people, 61.11%
Blood Pressure Fluctuation: 9 people, 50.00%
Pain: 9 people, 50.00%
Drug Ineffective: 8 people, 44.44%
Joint Pain: 6 people, 33.33%
Fever: 6 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 33.33%
Skin - Clammy: 5 people, 27.78%
Erythema Nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below): 5 people, 27.78%
Oropharyngeal Pain: 5 people, 27.78%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 8 people, 44.44%
Quit Smoking: 4 people, 22.22%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 22.22%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 22.22%
Cardiac Failure: 2 people, 11.11%
Pain: 1 person, 5.56%
Endometrial Cancer: 1 person, 5.56%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.56%
Breast Cancer: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Para and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Para:

Para (2,194 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

How severe was Hyperhidrosis and when was it recovered:

Hyperhidrosis in Para

Expand to all the drugs that have ingredients of para - aminobenzoic acid (paba):

Hyperhidrosis and drugs with ingredients of para - aminobenzoic acid (paba)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Para:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,579 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,529 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on para - aminobenzoic acid (paba) (the active ingredients of Para) and Para (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.